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Background: Histone post-translational modifications are critical determinants of chromatin structure and function,
impacting multiple biological processes including DNA transcription, replication, and repair. The post-translational
acetylation of histone H4 at lysine 16 (H4K16ac) was initially identified in association with dosage compensation of
the Drosophila male X chromosome. However, in mammalian cells, H4K16ac is not associated with dosage
compensation and the genomic distribution of H4K16ac is not precisely known. Therefore, we have mapped the
genome-wide H4K16ac distribution in human cells.
Results: We performed H4K16ac chromatin immunoprecipitation from human embryonic kidney 293 (HEK293) cells
followed by hybridization to whole-genome tiling arrays and identified 25,893 DNA regions (false discovery rate
<0.005) with average length of 692 nucleotides. Interestingly, although a majority of H4K16ac sites localized within
genes, only a relatively small fraction (~10%) was found near promoters, in contrast to the distribution of the
acetyltransferase, MOF, responsible for acetylation at K16 of H4. Using differential gene expression profiling data, 73
genes (> ±1.5-fold) were identified as potential H4K16ac-regulated genes. Seventeen transcription factor-binding
sites were significantly associated with H4K16ac occupancy (p < 0.0005). In addition, a consensus 12-nucleotide
guanine-rich sequence motif was identified in more than 55% of the H4K16ac peaks.
Conclusions: The results suggest that H4K16 acetylation has a limited effect on transcription regulation in HEK293
cells, whereas H4K16ac has been demonstrated to have critical roles in regulating transcription in mouse embryonic
stem cells. Thus, H4K16ac-dependent transcription regulation is likely a cell type specific process.
Keywords: Genome, H4K16ac, Gene expressionBackground
Covalent modifications of histone tails are thought to
alter chromatin structure, thereby controlling DNA
transcription, repair and replication. Acetylation of lysine
16 of histone H4 (H4K16ac) has the potential to create* Correspondence: nobuo.horikoshi@utsouthwestern.edu; shantanuc@igib.res.in;
tej.pandita@utsouthwestern.edu
†Equal contributors
1Department of Radiation Oncology, Division of Molecular Radiation Biology,
University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
4G.N.R. Center for Genome Informatics Unit, CSIR- Institute of Genomics and
Integrative Biology, Delhi, 110007, India
3Department of Radiation Oncology, Washington University School of
Medicine, St. Louis, MO, 63108, USA
Full list of author information is available at the end of the article
© 2013 Horikoshi et al.; licensee BioMed Centr
Commons Attribution License (http://creativec
reproduction in any medium, provided the oror secure binding platforms for transcriptional factors as
well as other chromatin-modifying enzymes [1,2]. Histone
H4 lysine 16 is acetylated by males absent on the first
(MOF, also called MYST1 or KAT8), a highly conserved
member of the MYST histone acetyltransferase (HAT)
family. MOF itself was originally discovered in Drosophila
as an essential component of the X chromosome dosage
compensation complex (DCC), also known as the male-
specific lethal (MSL) complex. MOF increases expression
of X-linked genes in male flies by 2-fold [3-6] and disrup-
tion of the MOF chromobarrel domain leads to genome-
wide H4K16ac loss and compromised MSL targeting to
X-linked genes [7]. In addition to its well defined role in
dosage compensation, MOF has recently been found atal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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flies, where it is bound as part of the nonspecific lethal
(NSL) complex [8-10]. Other members of the MYST
acetyltransferase family including acute myeloid leukemia
(MOZ), transcriptional silencing in Saccharomyces cerevisiae
(SAS2 and YBF2/SAS3), interactions with human
immunodeficiency virus Tat in humans (TIP60), are also
known to have transcriptional functions as well as roles in
DNA damage repair [11-19].
In mammals, MOF is essential for development.
Constitutive ablation of Mof leads to peri-implantation
embryonic lethality in mice [20,21]. MOF is also essential
for post-mitotic cell survival as Cre-mediated conditional
MOF deletion in Purkinje cells induces chromatin
blebbings and cell death, suggesting Mof has a crucial role
in maintenance of chromatin structures in vivo [22]. His-
tone acetylation has been suggested to have a role in both
transcriptional initiation and elongation as nucleosomes
present formidable barriers to the passage of Pol II during
transcriptional elongation [23] and global acetylation in
transcribed regions is required for increased basal levels of
transcription in yeast [24-26]. Acetylation of nucleosomal
histones in the region of transcription start sites (TSSs)
may stabilize the binding of chromatin remodeling factors
to promoter regions [27] and/or destabilize nucleosome
structure [28,29], leading to decreased nucleosome occu-
pancy at TSSs that facilitates RNA Pol II binding [30].
H4K16ac has been shown to impact higher order chro-
matin structure and create an open, highly accessible
environment [31,32] changing functional interactions
between chromatin-associated proteins [32], and serving
as a switch for altering chromatin from a repressive to a
transcriptionally active state in yeast and humans [33].
Tip60 (Tat-interacting protein) acetylates histones
H2A, H3 and H4 and plays a role in DNA repair [34]. In
Drosophila, Tip60 acetylates nucleosomal phospho-H2Av
and replaces it with an unmodified H2Av [16]. The
acetylation of histone H4 by Esa1 (essential SAS2-related
acetyltransferase1) is required for DNA repair in yeast [11]
and thus a similar modification may function in mamma-
lian cells. Depletion of human MOF (hMOF) in cells results
in a corresponding H4K16ac loss [13,19,35-37] indicating
that hMOF protein is the primary HAT responsible for
histone H4 acetylation at K16. Recent studies have
demonstrated that depletion of hMOF correlates with
decreased DNA damage-induced activation of ATM and
prevents ATM from phosphorylating downstream effectors,
such as H2AX, p53 and CHK2 [13,37]. Furthermore,
hMOF physically interacts with ATM [13,35] and hMOF
binds to and acts synergistically with p53 to increase
H4K16ac and target gene transcription in vitro [35]. In
yeast, the presence of H4K16ac and H2A.Z synergistically
prevent the ectopic propagation of heterochromatin in
subtelomeric regions [33].Consistent with these genetic and biochemical results,
genome-wide location analysis of HAT binding in yeast
demonstrated a good correlation with transcriptional
activation [38]. Numerous combinatorial patterns of
histone modifications, including those related to HATs,
in human CD4+ T cells have been studied on a genome-
wide scale [39,40] showing that modification patterns
change during cell differentiation [41-43]. Furthermore,
recent genome-wide binding analyses demonstrated that
mouse Mof plays a critical role in the Nanog-dependent
transcription network in mouse embryonic stem (ES)
cells [44]. In the present studies we determine the
genome-wide distribution of H4K16ac, the product of
MOF acetylation, and compared it with MOF-dependent
differential expression of genes in HEK293 human cancer
cells. Surprisingly, the potential contribution to gene
expression of H4K16ac in HEK293 cells is limited, as
opposed to results from ES cell studies, suggesting that
H4K16ac-dependent transcription regulation is cell
type-dependent and that MOF may have other important
roles in addition to transcriptional regulation through
H4K14ac modification.
Results and discussion
The histone code modification H4K16ac has been
identified in various organisms as a probable marker of
actively transcribed genes within euchromatin [45,46].
Acetylation of H4K16 is carried out by the MOF
acetyltransferase and while the genomic distribution of
MOF bound sites has been determined, a comprehensive
mapping and analysis of H4K16ac sites has not been
performed in human cells. To precisely identify all
H4K16ac genomic locations, we performed chromatin
immunoprecipitation (ChIP) from HEK293 cells with
an H4K16ac specific antibody followed by hybridization of
the co-precipitated DNA to NimbleGen whole-genome
tiling arrays. Analysis of the tiling data identified 25,893
high confidence DNA associated regions [false discovery
rate (FDR) <0.005] with an average length of 692 bases
that were distributed unevenly throughout the genome
(Figure 1). In general, there was a tendency for the regions
near chromosome ends to have areas with high H4K16ac
levels (41/46) while centromeric regions are largely free of
H4K14ac (43/46). At a finer level, the majority (82%) of
H4K16ac modification sites were located within genes:
45% within introns, 10% of sites 10 kb distal to annotated
TSS, 10% near transcription end sites (TES) and a rela-
tively small fraction of binding sites within exonic (3%)
and coding (2%) regions (Figure 2A). Gene-poor regions,
designated as intergenic regions, contain only 18% of
H4K16ac sites. These results are generally consistent
with the previously described analysis of Mof-associated
DNA regions [44] in mouse embryonic stem cells (ESCs),
where about 70% of sites were within genes, although a
Figure 1 Chromosomal distribution of H4K16ac sites. HEK293 cell genomic DNA was isolated and subjected to ChIP-ChIP analysis using an
antibody against H4K16ac and the NimbleGen Human Whole-Genome Tiling Array Set (see Materials and methods). Results are summarized for
each chromosome with the bar-height representing the regional log2H4K14ac intensity >2-fold.
Figure 2 Localization of H4K16ac peaks in the HEK293 genome. (A) Genome-wide distribution of H4K16ac peaks. H4K14ac peak distribution
was categorized as within exon, intron, coding and other genomic locations as described. Each bar represents the percentage of peaks in each
category. (B) Correlation of H4K16ac peaks and gene density in human chromosome 1. The bar graph for H4K16ac density and the gene density
map of human chromosome 1 are aligned. Although these two diagrams are well correlated (I and II), some regions show differences (III and IV).
(C) Gene ontology for the genes enriched by H4K16ac ChIP. A total of 3,538 genes identified as H4K16ac positive genes are subjected to gene
ontology analysis.
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coding regions. A general correlation of H4K16ac distribu-
tion with gene density in human chromosome 1 was ob-
served (regions I and II), although there were areas where
the H4K16ac distribution did not correlate with gene dens-
ity (regions III and IV) (Figure 2B).
To determine the role of H4K16ac histone modification
in regulating gene expression, we analyzed the spectrum of
H4K16ac sites genome-wide for locations within or near
genes. We found 5002 of the 25,893 H4K16ac sites local-
ized in 3538 unique genes within a region encompassing
10 kb upstream and downstream of annotated TSS.
Gene ontology and KEGG pathways analysis using the
GeneCodis2 web-based integrative knowledgebase [47]
for the 3538 genes revealed the highest enrichment for neu-
roactive ligand-receptor interactions, MAPK signaling, focal
adhesion, Wnt signaling, apoptosis and cancer pathways
(Figure 2C).
Examples of H4K16ac peak localization in promoter/
enhancer regions are shown in Figure 3A. The location
in the chromosome, H4K16ac peaks (red) and gene name
and exon/intron structure with transcription direction are
shown. As a potential regulatory mechanism of geneFigure 3 Distribution of H4K16ac in genes and its associated sequenc
(±10 kb of TSS; UCSC hg18) on 10 representative genes from different chro
binding sites with significant enrichment (p-value <0.0005) within H4K16ac
logo of the motif identified in H4K16ac-enriched DNA fragments.expression, we next asked whether these H4K16ac peaks
in or near genes overlap with transcription factor binding
sites. Using position weight matrices representing DNA
target sites for 184 transcription factors reported in the
TRANSFAC database, we determined the number of
these transcription factor-binding sites that were over-
represented near H4K16 acetylation sites (relative to ran-
domly selected control DNA fragments of the same size,
see Materials and methods). We found 17 transcription
factor-binding sites that were significantly associated with
H4K16 acetylated regions compared to control (p < 0.0005,
Figure 3B). Interestingly, all 17 transcription factor-binding
sites were localized near promoters of genes implicated in
cell cycle progression, proliferation and apoptosis. These
observations support the previous studies describing the
role of H4K16 acetylation in cell cycle regulation and cell
growth [44,48]. The H4K16ac associated DNAs were also
analyzed to determine whether a unique or novel DNA
motif was over-represented in the bound DNAs. Analysis
of all 25,893 binding peaks with the Gibbs motif sampler
[49] identified a 12-mer G-rich sequence motif (Figure 3C).
This motif is present at least once in more than 55% of all
H4K16ac peaks identified in HEK293 cells. Since this motifes. (A) Position of H4K16ac enriched fragments with respect to TSS
mosomes is shown based on ChIP-chip data. (B) Transcription factor
ChIP-chip peaks. Analysis was performed using TRANSFAC. (C) Sequence
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protein motif (antisense), co-occupancy analysis of
H4K16ac with CTCF DNA binding proteins was performed
which revealed that 13,230 unique peaks, corresponding to
51% of H4K16ac peaks, contained at least one CTCF motif
(data not shown).
Given that transcription factor binding motifs overlap
with H4K16ac sites localized near promoters, it is
possible that H4K16ac directly regulates gene expression
through effects on transcription factors. Therefore, we
also analyzed the H4K16ac peak distributions within
± 10 kb of gene TSS after dividing the genes into three
categories based on HEK293 cell expression levels: top
30%, middle 40%, and bottom 30%. The HEK293 cell
expression profile data were obtained from published
microarray data analysis [50]. Within ±10 kb of TSS for
the top 30% and middle 40% of expressed genes, the
H4K16ac peak distributions were clearly different from
those of MOF, which displayed a mono modal distribution
at the TSS in mouse ESCs as well as human CD4+ T cells
[44,51]. The H4K16ac density in the vicinity of TSS had a
V-shape distribution (Figure 4), with a minimum in peakFigure 4 Localization of H4K14ac peaks in genes. Untreated HEK293 ge
levels of entire genes and divided into three categories: top 30% high expr
between. In each category, H4K16ac peak distribution with respect to TSSintensity near the TSS that was lower in high and middle
level expression genes than in the low expression group but
then increased rapidly on either side of high and middle
expressed genes. Overall, the data indicate that
H4K16ac containing histone deposition has a complex
correlation with overall gene expression level in
HEK293 cells as proposed earlier [33].
The H4K16ac distribution profile in HEK293 cells is
similar to that observed in Drosophila and yeast
[8,52,53]. On the Drosophila X chromosome, MOF
displays a bimodal distribution, binding to the promoter
and 30 end regions of genes, whereas H4K16ac is prefer-
entially located at the 30 ends. Thus it seems likely that
MOF distribution is not identical to that of H4K16ac
and this tendency may be evolutionally conserved. MOF
forms MOF-NSL complexes that are enriched at TSSs
while a dosage compensation complex (DCC), also
known as the MOF-MSL complex, is enriched at 30 gene
regions. Although MOF is enzymatically active in both
complexes, H4K16ac is low at TSSs suggesting that the
MOF-NSL complex may be either less efficient or sub-
ject to site or cell type specific inhibition. Alternatively,ne expression profiling data were used to determine the expression
ession genes, bottom 30% low expression genes, middle 40% genes
was determined and displayed.
Horikoshi et al. Genome Integrity 2013, 4:3 Page 6 of 9
http://www.genomeintegrity.com/content/4/1/3H4K16ac modified nucleosomes may be displaced up or
down from TSS by alternative mechanisms involving
transcription initiation or elongation. In support of a role
for H4K16ac in transcription, a recent report demonstrated
that the enhanced gene expression occurring during X
chromosome dosage compensation in Drosophila is via
H4K16ac-dependent enhancement of transcriptional elong-
ation [53]. Perhaps in some HEK293 genes transcription
levels are enhanced by the distribution of H4K16ac
toward 30 ends of genes, possibly as MOF-MSL or similar
complexes support transcriptional elongation.
We next analyzed H4K16ac peaks within ±10 kb of
TSS for genes whose expression was altered in MOF-
depleted HEK293 cells using differential gene expression
profiles obtained previously from control and MOF
knockdown HEK293 cells [20,50]. Microarray profiling
revealed that 1020 genes (up: 426 genes, down: 594 genes)
were differentially expressed (fold change; >1.5) [50] which
is smaller than the 4475 genes that changed more than
2-fold in expression [44,48] in MOF conditional knockout
ESCs. Fewer genes may be differentially affected by MOF-
depletion in HEK293 cells due to cell type differences; ESCs
are rapidly growing pluripotent cells whereas HEK293 cells
are kidney cell-derived cancer cells simply undergoing con-
stant self-renewal. Thus, transcriptional regulation by MOF
may play a more significant role in ESCs than HEK293
cells, even though MOF is essential in both situations for
cell viability and proliferation [20,44]. Alternatively, the dif-
ferent results may be due to the fact that siRNA-mediated
MOF depletion is only partial (~85%), since total depletion
in 293 cells is lethal as is complete Mof gene knockout dur-
ing mouse embryogenesis [20]. Induced Mof gene knock-
out in mouse ESCs by Cre expression eventually
results in complete loss of Mof expression [44,48] and
these cells therefore may have initiated changes related
to cell death not observed during partial depletion.
Finally, we determined the number of genes with
altered expression following MOF depletion that also
harbored H4K16ac peaks within ±10 kb of the TSS.
Surprisingly, there were only 73 such genes, of which 26
were up- and 47 down-regulated (Figure 5A), a result
significantly less than the 1295 up-regulated and 1557
down-regulated genes detected at Mof binding sites in
mouse ESCs [44]. Ingenuity Pathway Analysis of the 73
genes indicated a majority were involved in cell cycle,
DNA replication, recombination, repair, or cancer related
pathways. The Nanog transcription network, which is a
critical direct MOF-dependent transcription group in
ESCs, was not enriched in HEK293 cells. Within the 73
gene subgroup, the H4K16ac distribution profiles for
up- and down-regulated genes did not display any unique
site differences that could account for differential ex-
pression (Figure 5B and 5C, respectively), though 5–10 kb
upstream of the TSS, up-regulated genes had a slightplateau in distribution that was lower overall compared to
the more irregular distribution seen in down-regulated
genes. These results suggest that H4K16ac distribution
does not correlate highly with transcriptional regulation in
HEK293 cells, where it may also play a smaller role than it
does in the critical self-renewal of mouse ESCs [44]. In
yeast, SAS-I-dependent H4K16 acetylation is reported to
be independent of transcription and histone exchange
[52]. It is also demonstrated in yeast that H4K16ac is
enriched in inactive genes [26]. Although, H4K16ac has
been linked to X chromosome transcriptional elongation
in Drosophila [53], MOF activates only a defined subset of
promoters [54]. In mammalian cells, phosphorylation of
H3 Ser10 during transcriptional activation leads to the re-
cruitment of MOF, which in turn modulates transcription
elongation via recruitment of BRD4 [2]. Indeed, MOF in
Drosophila directly binds in a bimodal fashion to the
promoters and 30-end of dosage-compensated genes on
the male X-chromosome and increases their expression
[8]. Thus, MOF may have different roles in transcriptional
regulation using different mechanisms that is organism
and cell type specific. Indeed, MOF in Drosophila has
been shown to have a critical role in DNA repair [55].
In summary, the present results imply that the role of
H4K16ac in transcription regulation is cell type-
dependent and possibly less important in differentiated
cells where other epigenetic marks, such as DNA
methylation, may override histone codes [56]. Interest-
ingly, even though MOF dependent H4K16ac has only
limited correlation with transcriptional regulation in
HEK293 cells, it is still required for cell survival. Fur-
thermore, only 13.44% of DNase I hypersensitive sites
are localized within 1 kb of H4K16ac peaks in HEK293
cells (Figure 5D), suggesting that the majority of
H4K16ac distributes to regions other than DNase I
hypersensitive sites and loss of H4K16 acetylation,
therefore, is unlikely to affect the global distribution of
DNase I hypersensitive sites. Interestingly, it has been
reported that the function of MOF is largely dependent
on the activities of tumor suppressors [57]. Therefore,
the critical role of MOF in transcriptional regulation
may be in combination with other transcriptional fac-
tors, such as FOXP3 [57]. In other words, MOF
dependent transcriptional regulation could be import-
ant only when cells are exposed to certain stimuli.
Overall, our results suggest that although MOF may
have a critical function in transcriptional regulation of
some genes in specific cell types, additional functions
other than transcriptional regulation underlie the re-
quirement for MOF/H4K16ac for cell survival. These crit-
ical functions may be related to MOF-mediated acetylation
of chromatin-associated proteins other than H4 or alter-
ations of chromatin structure induced by such modifi-
cations that are not detectable by DNaseI sensitivity.
Figure 5 H4K16ac distribution in genes differentially regulated by MOF status. (A) H4K16ac peak distribution in differentially expressed
genes. H4K14ac peaks are mapped within ±10 kb TSS with pink bars for each gene and the total H4K16ac distribution is shown in lower panel.
Genes are aligned according to relative changes in expression of the transcript as determined by microarrays on targeted depletion of H4K16ac
in HEK293 cells. (B) H4K16ac distribution in down-regulated genes (less than −1.5-fold). (C) H4K16ac distribution in up-regulated genes (more
than 1.5-fold). (D) DNase I hypersensitive sites are poorly correlated with H4K16ac peaks in HEK293 cells. Total H4K16ac peaks were analyzed for
DNase I hypersensitive sites. As shown in table, only 13.44% of H4K16ac peaks also contain DNase I hypersensitive sites within the region ±1 kb
from the peak.
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Identification of H4K16ac peaks in HEK293 cells
HEK293 cells were cultured as described previously
[13,20,50]. ChIP was performed in triplicate as described
[50] using anti-H4K16ac antibody (EMD Millipore,
Billerica, MA). Recovered DNA fragments were purified
and ChIP-chip was performed in Roche NimbleGen, Inc.
(Madison, WI). DNA without ChIP processing was used
as a reference. The differential gene expression profile was
obtained from GEO (accession number: GSE20193) [50].
Raw ChIP-chip fluorescence intensity data obtained from
NimbleGen Human ChIP-chip 2.1 M Whole-Genome
Tiling −10 Array Set (probe length: 50–75 mer, median
probe spacing 100 bp) were analyzed using Roche
NimbleScan 2.6 software. Settings included probe intensity
ratio calculation between experimental (ChIP) sample
and control (non-specific IgG) sample. Enrichment is
quantified by probe intensity log ratios calculated as the
base 2 logarithm of the ratio between the experimental
and control samples. Using the default parameters(probe length = 50 bp; P start = 90; P step = 1; # step = 76;
min probes > cutoff in peak = 4; when all probes in
peak > cutoff = 2 and width of sliding window = 500 bp)
peaks were identified at FDR <0.005. All coordinates in
this manuscript are reported in hg18 (GEO accession
number: GSE44254).
Identification of an H4K16ac binding DNA motif
To identify DNA sequence motifs in the H4K16ac-bound
regions detected by ChIP-chip, the sequences of all 25,893
H4K16ac-bound regions were retrieved from UCSC built
hg18 and inputted into the Gibbs sampler motif finding
program provided by CisGenome. The motif finder was
run searching for motifs of 12 bp using 5,000 MCMC
iterations and a score was produced for each motif.
Transcription factor binding site and DNase I
hypersensitive site enrichment analysis
For transcription factors enrichment analysis we first
generated ten control sequences by randomly picking
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Both the peak sequences and control sequences were
given as input into the Match tool to scan for enriched
PWMs listed in TRANSFAC professional. The total
occurrence of any given TFBS on each peak sequence
was considered as the observed frequency. Similarly, the
occurrence of a TFBS in control set sequences, gave the
randomly expected frequency. The discrepancy between
observed and expected frequency was evaluated by
determining the statistical variable chi-square (χ2).
The presence of CTCF motif within peak sequences
(FDR < 0.005) was looked for the presence of 9-mer
CTCF motif (AG[GA][GT]GG[CAT][GAT][CG] and
their complementary sequence). We found 13,230 unique
peaks (51% of overall peaks) with at least one 9-mer CTCF
motif. DNase I hypersensitive sites data for HEK293T cells
(a cell line derived from HEK293) were used for our
correlation analysis obtained form: http://genome.ucsc.
edu/cgi-bin/hgTrackUi?hgsid=302749441&c=chr6&g=wg
EncodeOpenChromDnase.
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